Live Quote · NASDAQGANXHealthcare· Biotechnology

Gain Therapeutics, Inc.

$1.00▼ 4.82%($-0.05)
MKT CAP $42.63MNEXT EARNINGS Mar 25, 2027
50%
Bullish
TickerSpark Score
51/100
▌ Mixed
60
Valuation
20
Profitability
60
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GANX research report →

Analyst Price Target
$5.00+400.3% vs. today

Range $5 – $5

Analyst RatingBuy
7 Buy1 Hold0 Sell

Price Chart

-64.93% · this period
$4.18$2.56$0.94Nov 20May 26Nov 20
52-Week Range2% of range
Low
$0.94
Current
$1.00
High
$4.34